Study Posting (180) -- Trial #88173, Multiple Myelomas, New York, NY

Click here to sign up to receive emails about new trial listings.

Trial Information

Summary: Phase I/II Study of Liposomal Doxorubicin (Doxil®)/ Melphalan/ Bortezomib (Velcade®) in Relapsed/Refractory Multiple Myeloma

The goals of this study are to examine a investigational combination of chemotherapy drugs including liposomal doxorubicin (Doxil®), melphalan, and bortezomib (Velcade®) and to see if this combination is safe and effective at controlling the multiple myeloma.

PRIMARY OBJECTIVE
To evaluate the safety and tolerability of four dose levels of liposomal doxorubicin, melphalan, and bortezomib in patients with relapsed/ refractory MM and to identify a maximum tolerated dose (MTD) of this combination.

SECONDARY OBJECTIVE
To determine the efficacy of DMV therapy using the following endpoints: The overall response rate, including complete, near complete, partial, and minimal response rate (CR + nCR + PR +MR) of relapsed/refractory MM to DMV combination therapy.

Time to response, progression-free survival, and overall survival.

Tabulate all the toxicities of DMV at the MTD by NCI criteria.

Contact:

Eva Diaz, Project Coordinator/Data Manager
Columbia University Medical Center
177 Fort Washington Ave
MBH 6 NK 435
New York, NY 10032
Telephone: 212-305-8857
Fax: 212-305-6798
Email:

Profile Page: Columbia University Medical Center, New York, NY

Maps by Google

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:
Name:
Address:
City:
State:
*Zip:
*Country:
Phone:
*Email address:
Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:41 AM

Back to Centerwatch Trial Listing by Location

Additional resources
in this illness area

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]